Lines of Credit and Long Term Debt

Lines of Credit

Trans Ova has a $5,000 revolving line of credit with First National Bank of Omaha which matures on May 1, 2018. The line of credit bears interest at the greater of 2.95% above the London Interbank Offered Rate or 3.00% and the actual rate was 4.19% as of September 30, 2017. As of September 30, 2017, there were no amounts outstanding. The amount available under the line of credit is based on eligible accounts receivable and inventory up to the maximum principal amount. The line of credit is collateralized by certain of Trans Ova's assets and contains certain restricted covenants that include maintaining minimum tangible net worth and working capital and maximum allowable annual capital expenditures. Trans Ova was in compliance with these covenants as of September 30, 2017.

Exemplar has a $700 revolving line of credit with American State Bank which matures on October 30, 2018. As of September 30, 2017, the interest rate on this line of credit was 4.50% per annum, and there was an outstanding balance of $234.

Long Term Debt

Long term debt consists of the following:



	September 30, 2017		December 31, 2016
Notes payable	$	5,122	$	5,453
Royalty-based financing	2,108		1,896
Other	882		599
Long term debt	8,112		7,948
Less current portion	439		386
Long term debt, less current portion	$	7,673	$	7,562

Trans Ova has a note payable to American State Bank which matures in April 2033 and has an outstanding principal balance of $4,967 as of September 30, 2017. Trans Ova pays monthly installments of $39, which includes interest at 3.95%. The note payable is collateralized by certain of Trans Ova's real estate and non-real estate assets.

AquaBounty has a royalty-based financing grant from the Atlantic Canada Opportunities Agency, a Canadian government agency, to provide funding of a research and development project. The total amount available under the award was $2,302, which AquaBounty claimed over a five year period. All amounts claimed by AquaBounty must be repaid in the form of a 10% royalty on any products commercialized out of this research and development project until fully paid. Because the timing of commercialization is subject to additional regulatory considerations, the timing of repayment is uncertain. As of the date of the acquisition by Intrexon in March 2013, AquaBounty had claimed $1,952 of the available funds and this amount was recorded at its acquisition date fair value of $1,107. The Company accretes the difference of $845 between the face value of amounts drawn and the acquisition date fair value over the expected period of repayment. Subsequent to the acquisition date, AquaBounty claimed the remaining balance available under the grant, resulting in total long term debt of $2,108 as of September 30, 2017.

Future maturities of long term debt are as follows:



2017	$	107
2018	462
2019	400
2020	371
2021	834
2022	360
Thereafter	3,470
Total	$	6,004

The AquaBounty royalty-based financing grant is not included in the table above due to the uncertainty of the timing of repayment.